Association of polymorphisms in the RAGE gene with serum CRP levels and coronary artery disease in the Chinese Han population

Journal of Human Genetics

Volumn 55, Issue 10, 2010, Pages 668-675

  Gao, Jinxiong ^a,b   Shao, Yahui ^a,c   Lai, Wenyan ^a,b   Ren, Hao ^a,b   Xu, Dingli ^a,b  

^a SOUTHERN MEDICAL UNIVERSITY   (China)

^b BEIJING UNIVERSITY OF POSTS AND TELECOMMUNICATIONS   (China)

^c JINAN MILITARY GENERAL HOSPITAL   (China)

Author keywords

coronary artery disease; CRP; hypertension; polymorphism; RAGE

Indexed keywords

C REACTIVE PROTEIN; GLYCINE; SERINE;

ADULT; ARTICLE; CARDIOVASCULAR RISK; CHINESE; CONFIDENCE INTERVAL; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DNA POLYMORPHISM; FEMALE; GENE; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC VARIABILITY; GENOTYPE; HAPLOTYPE; HUMAN; HYPERTENSION; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; POPULATION BASED CASE CONTROL STUDY; PROTEIN BLOOD LEVEL; RAGE GENE; RESTRICTION FRAGMENT LENGTH POLYMORPHISM;

AGED; ALLELES; ASIAN CONTINENTAL ANCESTRY GROUP; C-REACTIVE PROTEIN; CASE-CONTROL STUDIES; CHINA; CORONARY ARTERY DISEASE; FEMALE; GENE FREQUENCY; GENOTYPE; GLYCOSYLATION END PRODUCTS, ADVANCED; HAPLOTYPES; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; ODDS RATIO; POLYMORPHISM, GENETIC; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; RISK FACTORS;

EID: 78049315429     PISSN: 14345161     EISSN: None     Source Type: Journal    
DOI: 10.1038/jhg.2010.85     Document Type: Article

References (26)

1. Ramasamy, R., Vannucci, S. J., Yan, S. S. D., Herold, K., Yan, S. F. & Schmidt, A. M. Advanced glycation end products and RAGE: a common thread in aging, diabetes, neurodegeneration, and inflammation. Glycobiology 15, 16-28 (2005). (Pubitemid 41417992)
2. Hudson, B. I., Hofmann, M. A., Bucciarelli, L., Wendt, T., Moser, B., Lu, y et al. Glycation and diabetes: the RAGE connection. Curr. Sci. 83, 1515-1521 (2002). (Pubitemid 135698200)
3. Cipollone, F., Iezzi, A., Fazia, M., Zucchelli, M., Pini, B., Cuccurullo, C. et al. The receptor RAGE as a progression factor amplifying arachidonate-dependent inflammatory and proteolytic response in human atherosclerotic plaques: role of glycemic control. Circulation 108, 1070-1077 (2003). (Pubitemid 37071516)
4. Hudson, B. I. & Schmidt, A. M. RAGE: a novel target for drug intervention in diabetic vascular disease. Pharm. Res. 21, 1079-1086 (2004). (Pubitemid 38954190)
5. Laki, J., Kiszel, P., Vatay, A., Blasko, B., Kovacs, M., Körner, A. et al. The HLA 8.1 ancestral haplotype is strongly linked to the C allele of-429T>C promoter polymorphism of receptor of the advanced glycation endproduct (RAGE) gene. Haplotypeindependent association of the-429C allele with high hemoglobin (A1C) levels in diabetic patients. Mol. Immunol. 44, 648-655 (2007). (Pubitemid 44287036)
6. Hofmann, M. A., Drury, S., Hudson, B. I., Gleason, M. R., Qu, W., Lu, y et al. RAGE and arthritis: the G82S polymorphism amplifies the inflammatory response. Genes Immun. 3, 123-135 (2002). (Pubitemid 38961122)
7. Zhang, H. M., Chen, L. L., Wang, L., Liao, y F., Wu, Z. H., Ye, F et al. Association of 1704G/T and G82S polymorphisms in the receptor for advanced glycation end products gene with diabetic retinopathy in Chinese population. J. Endocrinol. Invest. 32, 258-262 (2009).
8. Jang, Y, Kim., J. Y, Kang, S. M., Kim, J. S., Chae, J. S., Kim, O. y et al. Association of the Gly82Ser polymorphism in the receptor for advanced glycation end products (RAGE) gene with circulating levels of soluble RAGE and inflammatory markers in nondiabetic and nonobese Koreans. Metabolism 56, 199-205 (2007). (Pubitemid 46074066)
9. Ridker, P. M., Buring, J. E., Cook, N. R. & Rifai, N. C-reactive protein, the metabolic syndrome, and risk of incident cardiovascular events: an 8-year follow-up of 14 719 initially healthy American women. Circulation 107, 391-397 (2003).
10. Zhong, Y., Li, S. H., Liu, S. M., Szmitko, P. E., He, X. Q., Fedak, P. W. et al. C-reactive protein upregulates receptor for advanced glycation end products expression in human endothelial cells. Hypertension 48, 504-511 (2006). (Pubitemid 44253747)
11. Wang, C. H., Li, S. H., Weisel, R. D., Fedak, P. W., Dumont, A. S., Szmitko, P. et al. C-reactive protein upregulates angiotensin type 1 receptors in vascular smooth muscle. Circulation 107, 1783-1790 (2003). (Pubitemid 36418360)
12. Xu, D. L., Liu, Y. L., Meng, S. R., Weng, C. H., Liu, Z. Q. & Liu, Y. L. Changes in serum concentration of the advanced glycosylation end-product N epsilon-(carboxymethyl) lysine in patients with coronary heart diseases. Chin. J. Geriatr. Cardiovasc. Cerebrovasc. Dis. 2, 161-163 (2000).
13. Zeng, P., Xu, D. L., Li, Z., Lai, W. Y. & Ren, H. Effects of advanced glycation endproducts on cell cycle distribution and apoptosis in neonatal rat cardiac myocytes. J. First. Mil. Med. Univ. 23, 9-11 (2003).
14. Shao, Y. H., Xu, D. L., Zeng, P., Lai, W. Y., Ren, H. & Jiang, R. Y. Transient cytosolic free calcium changes in cultured neonatal rat cardiac myocytes in response to advanced glycation end-product treatment. J. First. Mil. Med. Univ. 25, 274-276 (2005).
15. Kim, W., Hudson, B. I., Moser, B., Guo, J., Rong, L. L., Lu, Y. et al. Receptor for advanced glycation end products and its ligands: a journey from the complications of diabetes to its pathogenesis. Ann. NY Acad. Sci. 1043, 553-561 (2005). (Pubitemid 41123945)
16. Osawa, M., Yamamoto, Y., Munesue, S., Murakami, N., Sakurai, S., Watanabe, T. et al. De-N-glycosylation or G82S mutation of RAGE sensitizes its interaction with advanced glycation endproducts. Biochim. Biophys. Acta 1770, 1468-1474 (2007). (Pubitemid 47384994)
17. Chen, J. F., Huang, L., Song, M. B., Yu, S. Y., Gao, P. & Jing, J. C-reactive protein upregulates receptor for advanced glycation end products expression and alters antioxidant defenses in rat endothelial progenitor cells. J. Cardiovasc. Pharmacol. 53, 359-367 (2009).
18. Mahajan, N., Bahl, A. & Dhawan, V. C-reactive protein (CRP) up-regulates expression of receptor for advanced glycation end products (RAGE) and its inflammatory ligand EN-RAGE in THP-1 cells: inhibitory effects of atorvastatin. Int. J. Cardiol. 11733, 1-7 (2009).
19. Kankova, K., Zahejsky, J., Marova, I., Muzík, J., Kuhrova, V., Blazkova, M. et al. Polymorphisms in the RAGE gene influence susceptibility to diabetes-associated microvascular dermatoses in NIDDM. J. Diabetes Comp. 15, 185-192 (2001). (Pubitemid 33714178)
20. Vasku, V., Kankova, K., Vasku, A., Muzík, J., Izakovicova, H. L., Semradova, V. et al. Gene polymorphisms (G82S, 1704G/T, 2184A/G and 2245G/A) of the receptor of advanced glycation end products (RAGE) in plaque psoriasis. Arch. Dermatol. Res. 294, 127-130 (2002). (Pubitemid 34591574)
21. Hofmann, M. A., Yang, Q., Harja, E., Kedia, P., Gregersen, P. K., Cupples, L. A. et al. The RAGE Gly82Ser polymorphism is not associated with cardiovascular disease in the Framingham offspring study. Atherosclerosis 82, 301-305 (2005). (Pubitemid 41267198)
22. Yoon, S. J., Park, S., Shim, C. Y., Park, C. M., Ko, y G., Choi, D. et al. Association of RAGE gene polymorphisms with coronary artery disease in the Korean population. Coron. Artery Dis. 18, 1-8 (2007). (Pubitemid 44973749)
23. Kaplan, J. B. & Bennett, T. Use of race and ethnicity in biomedical publication. JAMA 289, 2709-2716 (2003). (Pubitemid 37430142)
24. Zee, R. Y., Romero, J. R., Gould, J. L., Ricupero, D. A. & Ridker, P. M. Polymorphisms in the advanced glycosylation end product-specific receptor gene and risk of incident myocardial infarction or ischemic stroke. Stroke 37, 1686-1690 (2006).
25. Yoshioka, K., Yoshida, T., Takakura, Y., Umekawa, T., Kogure, A., Toda, H. et al. Relation between polymorphisms G1704T and G82S of RAGE gene and diabetic retinopathy in Japanese type 2 diabetic patients. Intern. Med. 44, 417-421 (2005). (Pubitemid 40895094)
26. Xu, J. X., Xu, B. L., Yang, M. G. & Liu, S. Q.-429T/C and-374T/A polymorphisms of RAGE gene promoter are not associated with diabetic retinopathy in Chinese patients with type 2 diabetes. Diabet. Care 26, 2696-2697 (2003).